FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
about
Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory AnalysisPrognostic impact of FLT3-ITD load in NPM1 mutated acute myeloid leukemia.Diversity of the juxtamembrane and TKD1 mutations (exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data.Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.A Novel Tandem Duplication Assay to Detect Minimal Residual Disease in FLT3/ITD AML.Tandem duplication PCR: an ultrasensitive assay for the detection of internal tandem duplications of the FLT3 gene.Characteristics and Prognosis of Adult Acute Myeloid Leukemia with Internal Tandem Duplication in the FLT3 Gene.Interactive diagnostics in the indication to allogeneic SCT in AML.Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia.Minimal residual disease in acute myeloid leukemia--current status and future perspectives.DNA repair contributes to the drug-resistant phenotype of primary acute myeloid leukaemia cells with FLT3 internal tandem duplications and is reversed by the FLT3 inhibitor PKC412.Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia.Acute myeloid leukaemia blast cells with a tyrosine kinase domain mutation of FLT3 are less sensitive to lestaurtinib than those with a FLT3 internal tandem duplication.Advanced age and high initial WBC influence the outcome of inv(3) (q21q26)/t(3;3) (q21;q26) positive AML.Identification of emerging FLT3 ITD-positive clones during clinical remission and kinetics of disease relapse in acute myeloid leukaemia with mutated nucleophosmin.Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.Molecular stratification of patients with normal karyotype acute myeloid leukemia based on initial assessment of FLT3-internal tandem duplication status at first complete remission.The importance of FLT3 mutational analysis in acute myeloid leukemia.Monitoring of WT1 expression in PB and CD34(+) donor chimerism of BM predicts early relapse in AML and MDS patients after hematopoietic cell transplantation with reduced-intensity conditioning.Clinical impact of change of FLT3 mutation status in acute myeloid leukemia patients.Clonal heterogeneity of -ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemia
P2860
Q26797245-765F3D51-9B76-40E7-9DB6-02F4A3EBEB99Q27851642-11BF3765-4233-4EBB-B3E2-CCAF2DBE7608Q34295164-8A6C20F9-829B-4D1D-B616-B5EF60A2B21BQ36153422-88F1D20A-01A2-4097-9210-5BB69B90ED8BQ36304815-9578D77F-76DC-4396-A08D-D41C0BAC082DQ37097761-72462617-222C-4A94-8E33-C66A071DE8EBQ37274800-D136BAC5-187F-4643-9E31-A731548237DEQ37442649-E933E2BF-2F59-4081-9E29-4F14355ACE82Q38442612-C74C07B5-9B49-44C1-B4E6-30E56550EAD5Q38494659-17D3C988-36B8-4DB4-8FA4-3FA4286DE97BQ40215417-E6A8E479-4F59-4628-8524-4BA2A5280696Q42257952-CE2966CA-C1AA-4EE0-A41D-F7E15ABC48AAQ46701464-8FEF1C6E-6E44-4364-A12D-FD014E49592DQ46958461-7EFB5416-DDF7-475E-A3B6-ADE080C74597Q46985453-A1AF655A-8430-4DAB-89C7-9E3D22E26325Q47157978-95BB62EF-A5D5-4501-B171-25ABCC02B972Q47771912-AB62CA40-A424-406E-834E-4420A5076280Q48255430-11E9E5BF-ED06-422E-A9A8-C376ACD8121EQ54398542-CE73870B-9F38-4E9B-8A89-CA696C4D31D3Q54505356-92AF2775-C106-4744-BDC8-844FD77A3D8EQ56968572-C78CE3C5-DB68-4F76-AE5E-A1D57EC182B9
P2860
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@ast
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@en
type
label
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@ast
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@en
prefLabel
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@ast
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@en
P50
P356
P1433
P1476
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia.
@en
P2093
Wolfgang Hiddemann
Wolfgang Kern
P356
10.1159/000077561
P577
2004-01-01T00:00:00Z